← Back to Search

Other

T900607-Sodium for Ovarian Cancer

Phase 2

Waitlist Available

Research Sponsored by Tularik

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Histologically or cytologically confirmed diagnosis of ovarian cancer

At least 18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is testing a new drug to treat ovarian cancer to see if it is effective and safe.

Who is the study for?

This trial is for adults with ovarian cancer who've had 1-2 prior chemo treatments, including paclitaxel. They must have a certain level of health (specific blood counts and organ function), measurable disease by CT scan, be able to follow the study plan, and not be pregnant or breastfeeding. People with severe diseases, recent surgeries, heart issues, CNS metastases or other cancers in the last 5 years can't join.Check my eligibility

What is being tested?

The study tests T900607-sodium's effectiveness and safety in treating ovarian cancer in patients who have previously undergone chemotherapy. Participants will receive this investigational drug to see how well it works compared to their past treatments.See study design

What are the potential side effects?

While specific side effects are not listed here, common ones for cancer drugs include nausea, fatigue, risk of infection due to low blood cell counts, liver problems indicated by changes in certain lab values (AST/ALT/Bilirubin), kidney function affected as shown by creatinine levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My ovarian cancer diagnosis was confirmed through lab tests.

Select...

I am 18 years old or older.

Select...

I am able to care for myself but cannot do normal activities or work.

Select...

I have had 1-2 rounds of chemotherapy, including one with paclitaxel.

Select...

I have a tumor that can be seen and measured on a CT scan.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

TularikLead Sponsor

6 Previous Clinical Trials

890 Total Patients Enrolled

Kerrie BoydStudy ChairTularik

2 Previous Clinical Trials

105 Total Patients Enrolled

Media Library

T900607-Sodium (Other) Clinical Trial Eligibility Overview. Trial Name: NCT00043446 — Phase 2

Ovarian Tumors Clinical Trial 2023: T900607-Sodium Highlights & Side Effects. Trial Name: NCT00043446 — Phase 2

T900607-Sodium (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00043446 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any volunteers currently needed for this experiment?

"Unfortunately, this particular study is not enrolling patients at the moment. According to information found on clinicaltrials.gov, which was last updated on June 23rd, 2005, this trial is no longer recruiting participants. However, there are 520 other trials that are still currently looking for patients to enroll."

Answered by AI

Are elderly citizens being recruited for this clinical trial?

"Patients that meet the age criteria of 18-65 years old are eligible for this clinical trial. There are 15 other trials targeting a younger demographic and 511 trials for an older population."

Answered by AI

Are there any restrictions or requirements to take part in this research?

"Eligibility requirements for this ovarian cancer clinical trial include being aged 18 or older. A total of 35 patients will be enrolled in the study."

Answered by AI

Does this treatment come with any risks?

"There is only preliminary data supporting the safety of this treatment, as it has only reached Phase 2 in clinical trials. There are no efficacy data available at this time."

Answered by AI

In how many different geographical areas is this trial being conducted?

"Five hospitals are participating in this trial, they are USC Women's and Children's Hospital located in Los Angeles, Scripps Health Center situated in La Jolla, University of California San Francisco found in San Francisco. Additionally, there are two other sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.

2002. "Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00043446.

All > Ovarian Cancer